BioSpace News Archive

Centricity Vision Inc., a global ophthalmic technology company, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the new ZEPTOLink™ IOL Positioning System.

METAFORA biosystems, announces that the Haute Autorité de Santé, the French Health Technology Agency, has issued a recommendation for insurance coverage of METAglut1TM, a test for the early diagnosis of De Vivo disease, a rare neurometabolic disorder.

Gain Therapeutics, Inc. (Nasdaq: GANX), a biotechnology company leading the discovery and development of allosteric small molecule therapies, today announced that Innosuisse, the Swiss Innovation Agency, supports GT Gain Therapeutics SA with the amount of CHF 2.5 million (~$2.8 million) to develop GT-02287, Gain’s lead program for GBA1 Parkinson’s disease.

Yield10 Bioscience, Inc. announced that it has agreed to sell $3.0 million of its shares of common stock in a registered direct offering and warrants in a concurrent private placement with investors including a certain institutional investor and an existing investor.

Eli Lilly and Company will participate in the Bank of America Securities 2023 Healthcare Conference, May 9-11, 2023.

The Insight Partners published latest research report on “Small Molecule Drug Discovery Market Size Report, Share, Growth & Trends Forecast to 2027 - COVID-19 Impact and Global Analysis by Therapeutic Area; Process/Phase; and Geography”,

BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) is pleased to announce that VINIA®, the first product developed on its proprietary Bio-Plant CELLicitation platform, has been recognized as an Honorable mention in the Wellness category of Fast Company’s 2023 World Changing Ideas Awards.

RaySearch Laboratories AB announces that New York University Langone Hospital - Long Island in Mineola, New York, has placed an order for the treatment planning system RayStation®*.

Glidewell, the largest full-service dental laboratory in North America and a leading provider of dental products and services for more than 50 years, has entered into an agreement to distribute Carestream Dental’s cone beam computed tomography imaging systems in the United States and Canada.

Today, the U.S. Food and Drug Administration approved Arexvy, the first respiratory syncytial virus (RSV) vaccine approved for use in the United States.